News
InsCer starts producing radiopharmaceuticals for R2IBF customers
On November 9, the Brain Institute of Rio Grande do Sul signed a contract with the R2IBF group, a company focused on the production and development of high quality radiopharmaceuticals. As of March 2021, all product manufacturing for R2 customers in the states of Rio Grande do Sul and southern...
11 de Novembro de 2020